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Abstract
Background: Orf virus (ORFV) is the causative agent of Orf (also known as contagious ecthyma or contagious
papular dermatitis), a severe infectious skin disease in goats, sheep and other ruminants. The rapid detection of
ORFV is of great importance in disease control and highly needed. A isothermal molecular diagnostic approach,
termed recombinase polymerase amplification (RPA), is considered as an novel and rapid alternative techonology to
PCR assay.
Results: In the present study, a novel fluorescent probe based on RPA assay (ORFV exo RPA assay) was developed.
The developed ORFV exo RPA assay was capable of as low as 100 copies of ORFV DNA /reaction and was highly
specific, with no cross-reaction with closely related viruses (capripox virus, foot-and-mouth disease virus or peste
des petits ruminants virus). Further assessment with clinical samples showed that the developed ORFV exo RPA
assay has good correlation with qPCR assays for detection of ORFV.
Conclusions: These results suggest that the developed ORFV exo RPA assay is suitable for rapid detection of ORFV.
Keywords: Recombinase polymerase amplification assay, RPA assay, Orf virus, Small ruminants
Background
The Orf virus (ORFV) is a prototype member of the
Parapoxvirus genus within the Poxviridae family and the
viral genome consists of a linear double-stranded DNA
(137–139 kbp in length). ORFV is the causative agent of
contagious ecthyma or contagious papular dermatitis
(Orf ) in goats, sheep and other ruminants, with a
worldwide distribution and significant financial import-
ance [1, 2]. The clinical symptoms of Orf manifest as
the formation of papules, vesicles and growing scabs on
the lips and muzzle of infected animals [3, 4]. Orf is
usually more severe in goats than in sheep and the
morbidity of the disease may reach up to 100 %. The
mortality is usually not high but can reach up to 90 %
in susceptible flocks of young sheep in an epidemic
situation [5, 6]. Furthermore, the disease has zoonotic
potential which adds to the significance of the disease
to public health. Therefore, the rapid detection of
ORFV is of great importance in disease control and
highly needed.
Although clinical signs relating to the oral mucosa
and lips are indicative of Orf, a laboratory diagnosis is
necessary for confirmation and epidemiological inves-
tigations. Traditional laboratory diagnostic methods
include virus isolation, electron microscopy and serum
neutralization [7]. However, these methods are labori-
ous and time-consuming. Detection of serum antibody
is also not effective because of the cell-mediated na-
ture of ORFV immunity. Recently, a number of nu-
cleic acid-based methods (such as PCR, PCR-
restriction enzyme digestion and real-time PCR) have
been developed for accurate and rapid diagnosis of
Orf [7–10]. Among these assays, real-time quantitative
PCR (qPCR) has shown to be a highly sensitive and
specific assay for detection and quantification of
ORFV in clinical samples and is able to differentiate
from related viruses. However, qPCR assay relies on
specialized and expensive thermocycling machines, as
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a result it is difficult to be used as a “pen-side” test
and in endemic areas with low resources.
In recent years, a novel and rapid isothermal molecu-
lar diagnostic approach, termed recombinase polymerase
amplification(RPA), has been developed as an alternative
to PCR assay. The RPA technology employs three core
enzymes: a recombinase, a single-stranded DNA-binding
protein (SSB) and a strand-displacing polymerase. Dur-
ing the RPA reaction, recombinases first pairs oligo-
nucleotide primers with homologous sequences in
duplex DNA. SSB binds to displaced strands of DNA
and prevents the primers from being displaced. Then
the strand-displacing polymerase begins DNA synthesis
at sites where the primer has bound to the target DNA.
Real-time detection can be achieved by adding exonucle-
ase III and exo probes to the reaction mixture. Import-
antly, RPA reaction can be performed between 37 ~ 42 °
C without requirement of any sophisticated equipment.
In comparison to loop-mediated isothermal amplifica-
tion (LAMP) [11, 12], which requires a larger set of six
primers, a higher temperature (62 °C) and a longer run
time, RPA is more rapid and simpler to run, which just
needs a pair of primers [13–15], a lower temperature
(37 to 42 °C) and a shorter run time (less than 20 min).
Since its initial development in 2006, RPA technology
has been successfully used for rapid detection of vari-
ous pathogens [16–21]. In the present study, a fluores-
cent probe-based RPA assay has been developed and
evaluated for rapid detection of ORFV. To the best of
our knowledge, a RPA assay has not been developed for
detection of ORFV yet. After determination of the sen-
sitivity and specificity of the assay, clinical samples
from sheep were tested and compared with results from
the corresponding qPCR assay.
Methods
Virus and cells
All viruses used in this study were preserved in our la-
boratory: ORFV/Vaccine/CHA, ORFV/Gansu/CHA,
ORFV/HB/CHA; Capripox virus CHA vaccine strain,
Capripox virus/Henan/CHA; peste des petits ruminants
virus (PPRV) Nigeria 75/1; foot-and-mouth disease virus
(FMDV)/O/CHA, FMDV/A/CHA and FMDV/Asia 1
/CHA. A549 cells were preserved in our laboratory and
cultured in minimal essential medium (MEM) contain-
ing 10 % fetal bovine serum (FBS) at 37 °C, 5 % CO2.
Sample preparation
Twenty two field samples (n = 22) were collected from
suspected goats of Orf and eight nasal swabs collected
from eight experimentally infected sheep. Swabs were
placed immediately after collection in 1 ml phosphate-
buffered saline (PBS) and stored at −80 °C until used. To
prepare ORFV-spiked tissues lysates, ORFV-free tissues
samples of skin, lymphatic nodes liver, lungs, stomach
and kidney (n = 24, three each tissue) were collected
from four healthy sheep. ORFV is an epitheliotropic
virus, therefore sample of skin tissue was selected. In
addition, samples of other tissues were also chosen
because various types of tissues are often received in the
field diagnostics for differential diagnosis including non-
epitheliotropic viruses such as PPRV, so it would be
critical to access the compatibility of the developed RPA
assay with different tissues matrix. 10 % (w/vol) tissue
suspensions were then prepared by homogenizing tissue
samples in PBS. Following a brief centrifugation, the
homogenized tissue samples were spiked with 104
TCID50 of ORFV/HB/CHA and stored at −80 °C until
used. To prepare ORFV infected A549 cells (human lung
adenocarcinoma cells, provided by our laboratory), the
A549 cells were seeded at 1 × 106 cells/well in 6 well-
plates and cultured overnight in MEM containing 10 %
FBS and incubated overnight at 37 °C, 5 % CO2.
Growth medium was removed and 100 μL of ORFV/
Vaccine/CHA, ORFV/Gansu/CHA and ORFV/ HB/
CHA in medium with 2 % FBS was added into their
own wells, respectively. Cells in negative control well
were maintained in medium with no ORFV. After 1 h
of adsorption at 37 °C, the cells were washed gently
three times with serum free medium and then main-
tained in MEM containing 2 % FBS at 37 °C, 5 % CO2.
The cells were harvested at 12, 24, 36, 48 and 60 h after
inoculation (hpi) and stored at −80 °C until use.
DNA extraction
Total DNA was extracted from samples using high pure
viral nucleic acid kit (Roche) according to the manufac-
turer’s instructions and eluted in a final volume of 50 μL.
Extracted DNA was stored at −80°Cuntil further use.
Generation of DNA standard
The ORFV DNA polymerase gene segments (305 bp)
were synthesized by Genewiz (Suzhou, China) and
cloned into a pUC57 vector, designated as pORFV/
RP1. pORFV/RP1 plasmid DNA were extracted using
Plasmid Mini kit I (Promega, USA) and then measured
by Nanovue (GE lifescience). The DNA copy number
was calculated using the following equation [18]: DNA
copy number = (M× 6.02 × 1023 × 10−9)/(n × 660). The
DNA standard was then aliquoted and stored at −80 °
C until use.
RPA primers and probe
ORFV-specific RPA primers and probes, based on the
highly conserved DNA polymerase gene coding sequence
of ORFV, were designed according to RPA guidelines from
TwistDx (Cambridge, United Kingdom). All ORFV DNA
polymerase gene coding sequence genes were retrieved
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from GenBank and multiple sequence alignment of
the gene sequences were manually designed based on
the ORFV DNA polymerase gene recommendation by
TwistDx (Cambridge, UK). All primers and probes were
synthesized by Sangon Biotech (Shanghai, China). Probes
were synthesized with an inverse arrangement of fluoro-
phore (6-carboxyfluorescein [FAM]), quencher (black hole
quencher 1 [BHQ-1]), spacer(tetrahydrofuran spacer[THF])
and block elongation(phosphate[P]).
Real-time qPCR assay
Real-time qPCR assay was performed with SYBR ® Select
Master Mix on Aglient Technologies Stratagene Mx3005P
thermocycler (Life technologies) as previously described
[22]. The reactions were prepared as a 20 μL reaction
volume containing SYBR® Select Master Mix (2X), the
forward and reverse primers (10 μM, 1 μL each) and 2 μL
of DNA template. The cycling parameters were as follows:
50 °C for 5 min, 95 °C for 10 min, 40 cycles at 95 °C for
15 s and 60 °C for 1 min. A melting curve analysis was
performed using its specific melting temperature to verify
the uniqueness of the amplified product. The data were
analyzed using Mx3005P System software.
Probe-based exo RPA assay
Exo RPA reactions were performed in a 50 μL volume
using enzyme pellets from the TwistAmp exo kit
(TwistDx, Cambridge, United Kingdom), which con-
sisted of 27.5 μL rehydration buffer, 2 μL template
DNA, 2.1 μL of forward and reverse primers (10 μM,
BGI.tech), 0.6 μL of RPA exo probe (10 μM, Sangon
Biotech), 11.2 μL of ddH2O and 2.5 μL of magnesium
acetate (280 mM). The assay was performed on Aglient
Technologies Stratagene Mx3005P thermocycler (Life
technologies) for 60 cycles at 40 °C for 20s. The
reaction was completed in 20 min. Optimal reaction
conditions were defined after testing different incubation
temperatures (39 to 42 °C), as well as different concentra-
tions of template (0.5 μL to 2 μL) and magnesium acetate
(1 μL to 2.5 μL). During initial experiments, the original
50 μL volume of the RPA reaction was successfully
reduced to 25 μL. Fluorescence intensity of FAM was
determined every 20 s. A sample was deemed positive if
all replicates were three and a half standard deviations
(3.5SD) above the background during a defined time range
(i.e. after 19 to 20 min of amplification). A threshold time
range of 0 to 4 min and 30 s was used.
Statistic analysis
Data values are provided as the mean and standard
deviation (SD). Statistical analysis was performed using
PRISM 5.0 software (GraphPad Software, USA).
Results
Sensitivity and specificity of ORFV exo RPA assay
Initially in order to determine the most efficient primer
pair for ORFV exo RPA assay, three forward primers
(F1-F3) and reverse primers (R1-R3) based on different
regions of ORFV DNA polymerase gene were designed
(Table 1). Nine different combination of primers (i.e. F1/
R1, F1/R2, F1/R3, F2/R1, F2/R2 F2/R3, F3/R1, F3/R2,
F3/R3) were then tested with the exo probe ORFV RPA
P on 104 genome copies of standard DNA. The result
showed that the primer set F1/R1 yielded the highest
efficiency of amplification (data was shown in Additional
file 1: Figure S1). Therefore, this pair of primers were
employed in ORFV exo RPA assay for further validation.
To test the dynamic range of ORFV exo RPA assay,
standard DNA from pORFV/RP1 was diluted 10-fold,
ranging from 101 - 106 genome copies per reaction and
then tested by ORFV exo RPA assay. Every run was
repeated 8 times. The threshold time was plotted
against log (detected molecules), and a semi-log
regression was calculated using PRISM 5.0 software
(GraphPad Software, USA). As shown in Fig 1, the
dynamic detection range of the assay spans 5 logs
ranging from 6 to 2 log copies per reaction, with the
corresponding threshold time ranging from 2 min at
106 copies/reaction to 10 min at 102 copies/reaction.
This result indicates that ORFV exo RPA assay has a wide
Table 1 RPA primers and probes designed in this study
Name Sequence (5’ –3’) Genome location(U33419.1)
ORFVRPA F1 CTAGTAAGCTGTTCGAGATCACCTTGTTCATCATG 4465-4499
ORFV RPA F2 TTCCGACGGACGTATGAATATGTCCATGGTGAACG 4530-4564
ORFV RPA F3 CGTATGAATATGTCCATGGTGAACGATGTACCAAC 4540-4574
ORFV RPA R1 AGCGTTCATTCAATTCATGTCTGAGGTAAACGGCA 4702-4736
ORFV RPA R2 GACCACGTAAAAGTGGTGTTCGAAAAACTTCACAA 4651-4685
ORFV RPA R3 GGTAAACGGCAATGATGTTCGTGACAAAGACCACG 4679-4713
ORFV RPA P AACGTATCCCATGCAGTAAAGCATAGTCCG 4582-4631
(FAM-dT)C(THF)C(BHQ1-dT)TATAAACTCAGGAAC-p
ORFV RPA F and R, RPA primer; ORFV RPA P, RPA Exo probe; BHQ1-dT, thymidine nucleotide carrying Black Hole Quencher 1; THF, tetrahydrofuran spacer; FAM-dT,
thymidine nucleotide carrying fluorescein; P (phosphate), block elongation
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dynamic range for quantifying target DNA (Fig. 1a, b).
The detection limit of ORFV exo RPA assay at 95 %
probability was 102 copies per reaction (probit analysis,
p ≤ 0.05) (Fig 1c). The specificity of ORFV exo RPA
assay was determined by cross detection of other
viruses that infect sheep and goat epithelium or mucus
including FMDV serotypes O, A and Asia 1, PPRV and
Capripox virus. No cross detections were observed and
all three different ORFV strains could be detected by
the developed ORFV exo RPA assay (Table 2).
To further determine the sensitivity of ORFV exo
RPA assay, extracted ORFV DNA from ORFV-infected
A549 cells collected at 12, 24, 36, 48 and 60 hpi were
evaluated (2 samples each time point). The amplifica-
tion of ORFV DNA in ORFV-infected A549 cells was
shown successfully from as early as 12 hpi, with
threshold time (min) ranging from 6.8 ± 0.3 at 12hpi
to 4.3 ± 0.4 at 60hpi. There was no amplification
detected in the non-infected A549 cells used as nega-
tive control for this assay even through the threshold
Fig. 1 Performance of the ORFV exo RPA assay. a Amplification curve of ORFV exo RPA assay over time using a dilution range of 106 to 101
copies/reaction of ORFV. NC represent negative control. b Reproducibility of the ORFV exo RPA assay. The threshold time is represented as the
mean ± standard deviation (SD). The standard regression line was generated based on 8 data sets (c) Probit regression analysis using Statistics
software was done on data from the eight runs of ORFV exo RPA assay. The limit of detection at 95 % probability is depicted by a triangle
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time (min) was greater than 30 min. These results
were 100 % in agreement with these of real-time
ORFV qPCR assay (a CT value ranging from 23.98 ± 0.2
to 14.8 ± 0.1). As a further investigation to verify sensi-
tivity, the developed ORFV exo RPA assay was further
tested using samples of ORFV-spiked tissues lysates
(n = 24). Results showed that all the virus-spiked
samples were positive for ORFV DNA, with threshold
time (min) ranging from 7.1 ± 0.4 to 5.8 ± 1.1. There
was no amplification detected in the non-virus-spiked
samples despite threshold time being over 30 min.
These results were 100 % confirmed by real-time
ORFV qPCR assay (a CT value ranging from 18.4 ± 0.8
to 21 ± .0.9). Both assays showed the same perform-
ance on the samples above and correlation was found
between values of the cycle threshold (qPCR) and
threshold time (PRA) (R squared 0.64, Fig. 2).
Performance of ORFV exo RPA assay on clinical samples
The practicality and efficiency of the ORFV exo RPA
assay was evaluated with clinical samples and then
compared with real-time ORFV qPCR assay. The clinical
samples included twenty two samples (n = 22) collected
from suspected cases of Orf, eight nasal swabs collected
from experimentally infected sheep and five samples
obtained from healthy goats. There was no amplification
detected in samples (n = 5) obtained from healthy goats
even through threshold time (min) exceeded 30 min.
Nasal swabs (n = 8) were positive for ORFV through
ORFV exo RPA assay (average threshold time = 6.3 ± 1.3,
ranging from 4.6 to 8.6). Both results above were 100 %
in agreement with these of the real-time ORFV qPCR
(average CT value 21.3 ± 0.3, ranging from 16.6 to 26.2).
Of 22 samples collected from suspected cases of the Orf,
six samples were determined to be positive by ORFV
exo RPA assay (threshold time ranging from 4.3 to 7.3)
while eight samples were found to be positive by real-
time ORFV qPCR assay (CT value ranging from 15.3 to
32.8). For the two samples found negative by ORFV exo
RPA assay, the PCR assay CT value were the lowest
(31.8 and 32.8, respectively). Based on a total of 35
samples examined, the sensitivity and the specificity of
ORFV exo RPA assay for identification of ORFV was
86 % and 100 % respectively when compared to real-
time ORFV qPCR (Table 3).
Table 2 Evaluation of the specificity of ORFV exo PRA assay
Virus family Virus specie Virus strain exo RPA qPCR
Poxviridae ORFV ORFV/Vaccine/CHA 5 min 12(CT)
ORFV ORFV/Gansu/CHA 3 min 9(CT)
ORFV ORFV/HB/CHA 4 min 11(CT)
Poxviridae other than ORFV Capripox Capripox virus/China Vaccine neg neg
Capripox Capripox virus/Henan/CHA neg neg
Paramyxovirinae PPRV Nigeria 75/1 neg neg
Picornaviridae FMDV FMDV/O/CHA neg neg
FMDV FMDV/A/CHA neg neg



















Fig. 2 Comparison between performances of ORFV exo RPA
assay and real-time ORFV qPCR assay on samples of ORFV-infected cells
(n = 15) and spiked tissues lysates (n = 24). Linear regression analysis of
the exo RPA threshold time (y axis) and qPCR cycle threshold (CT)
values (x axis) were determined by Excel software




RPA Positive 14 0 14
Negative 2 19 21
16 19 35
aSamples include twenty two samples collected from suspected cases of the
orf, eight nasal swabs collected from experimentally infected sheep and five
samples obtained from healthy goats. All samples either ORFV or no viral
DNAs detected
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Discussion
In the present study, a novel fluorescent probe-based
RPA assay (ORFV exo RPA assay) was developed and
evaluated for detection of ORFV. We demonstrated that
the developed ORFV exo RPA assay could detect ORFV
at a copy as low as 100 genome copies/reaction, further-
more the results have demonstrated that the developed
ORFV RPA exo assay only specifically detects ORFV.
Our data from ORFV-infected A549 cell line has
shown that ORFV DNA levels increases over time after
inoculation, which indicates the potential capability for
quantification of the virus in samples and also that A549
cell line could be a proper cell line for ORFV replication
and propagation. No amplification was observed in non-
ORFV infected cells/homogenizing tissue samples, this
indicates the high specificity of ORFV exo RPA assay in
this study. The apparent sensitivity of ORFV exo RPA
assay for identification of ORFV in clinical samples was
found to be 86 % when compared to real-time ORFV
qPCR assay. We believe that this is due to the slightly
lower sensitivity of ORFV exo RPA assay and the fact
that those two samples were shown to be only weakly
positive by real-time ORFV qPCR (a Ct value > 31). The
Ct value of such ORFV qPCR positive/ORFV exo RPA
negative samples were lower than that of the ORFV
qPCR-positive/ORFV exo RPA positive samples. The
results taken together indicate that the sensitivity and
specificity of ORFV exo RPA assay, using F1/R1 primer
set based on the region of ORFV DNA polymerase gene
sequences, is comparable to real-time ORFV qPCR assay
for detection of ORFV. A recent study showed that the
sensitivity of RPA remains slightly lower than that of
LAMP assay [23]. In comparison to RT-PCR and LAMP
assays, RPA is a relatively novel and less evaluated
technology. It is participated that its sensitivity could be
further improved as the technology develops and the
reaction conditions including RPA primers are fully
optimized and evaluated. It is worth mentioning that
maximal running time the developed ORFV exo RPA
assay required is 30 min, regardless of the viral concen-
tration present in samples as long as it is above the
detection limit (i.e. > 100 copies per reaction).
In comparison, to the loop-mediated isothermal
amplification (LAMP) technology, which requires a
larger set of six primers, a higher temperature (62 °C)
and a longer run time, the developed ORFV exo RPA
assay is simpler and more rapid. The result can be
obtained in less than 20 min and a lower reaction
temperature of 37 ~ 39 °C is needed, which is an advan-
tage with regard to miniaturization and integration into
pen-side tests. In addition, it has high specificity due to
the fact that RPA uses specific detection probes, like
real-time PCR assay does, while LAMP uses non-
specific intercalating fluorophores [18, 24, 25]. Unlike
LAMP assay,the specificity of the real-time fluorescent
probe-based RPA assay based on TwistAmp exo kit, which
was used in this study, cannot be checked in agarose gel,
because the exonuclease present in the reaction mixture
digests most of the amplified product once amplification
has ceased. However, amplicons can be checked in agarose
gel when TwistAmp basic kit or TwistAmp nfo kit in
which the exonuclease is not included, is used, as we
demonstrated with a specific band of amplified ORFV
product in the gel electrophoresis based on TwistAmp
basic kit (Additional file 2: Figure S2). Therefore, RPA has
good flexibility in adaption into various detection systems.
Conclusions
The ORFV exo RPA assay described is sensitive and specific
for rapid detection of ORFV within less than 30 min. The
results are encouraging but the assay must be validated by
analysis of a larger number of samples from animals
infected with ORFV and with different strains before such
an assay can be considered for routine diagnostic use.
Additional files
Additional file 1: Figure S1. Three forward primes (F1-F3), one probe
and three reverse primers (R1-R3) were tested to select combinations
yielding the highest analytical RPA sensitivity. The amplification results of
nine different combination of primers with the exo probe ORFV RPA P
(i.e. 1: F1/R1, 2: F2/R2, 3: F1/R2, 4: F2/R1, 5: F1/R3, 6: F2/R3, 7: F3/R1,8:
F3/R2,9: F3/R3, 10: NC) were shown in the figure. Standard DNA of 104
genome copies were used as template. (DOCX 24 kb)
Additional file 2: Figure S2. Analysis of the sensitivity of the
recombinase polymerase amplification in agarose gel. TwistAmp
basic Kit was used in this reaction. A serial dilution of the ORFV
DNA standard plasmids. Positive RPA reaction products (273 bp)
can be detected on a stained agarose gel (2 %) (A). NC represent
negative control. (DOCX 38 kb)
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